Avis Budget Group, Inc.
$10.03B- Market cap
- $4.48B
- Debt
- +$6.07B
- Cash
- −$519.00M
Capital structure 42% equity / 58% debt · EV / Revenue 0.86x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: CAR stock price at discount vs ABBV $126.74 current versus $2.43K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ABBV's multiple
Implied fair value · at CAR's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Multiple discount
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 42% equity / 58% debt · EV / Revenue 0.86x
Capital structure 87% equity / 13% debt · EV / Revenue 8.35x · EV proxy / EBITDA proxy 21.99x
ABBV carries the larger enterprise value at $510.38B against $10.03B; CAR trades on the lower EV / Revenue multiple (0.86x vs 8.35x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AVIS BUDGET GROUP, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
AbbVie Inc. · implied price per share
Bear
$87.89
Base
$110.94
Bull
$142.98
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Uber Technologies, Inc
CAR vs UBER
FORD MOTOR CO
CAR vs F
General Motors Co
CAR vs GM
HUNT J B TRANSPORT SERVICES INC
CAR vs JBHT
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
CAR vs WAB
OLD DOMINION FREIGHT LINE, INC.
CAR vs ODFL
Pfizer Inc.
CAR vs PFE
Johnson & Johnson
CAR vs JNJ
Merck & Co., Inc.
CAR vs MRK
Eli Lilly and Company
CAR vs LLY
Amgen Inc.
CAR vs AMGN
Gilead Sciences, Inc.
CAR vs GILD
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.